Mission Therapeutics Appoints Dr Suhail Nurbhai as Chief Medical Officer
CAMBRIDGE, UK– 2 November 2020 – Mission Therapeutics, a drug discovery and development company focused on selectively inhibiting deubiquitylating enzymes (DUBs), has appointed Dr Suhail Nurbhai as Chief Medical Officer (CMO) with immediate effect. Dr Nurbhai has more than 25 years of experience and a strong track record in the strategic and operational leadership of […]